Showing results (461-470 of 494) with videos related to
Sort By:
Pageof 50
Annals of Surgical Oncology|October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapyN Q Mirza, G Vlastos, F Meric, et al.International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapySean E McGuire, Ana M Gonzalez-Angulo, Eugene H Huang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2021
Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancerXiangjie Sun, Jie Zhai, Baohua Sun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeksMarjorie C Green, Aman U Buzdar, Terry Smith, et al.Human Pathology|April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinomaEsther C Yoon, Gang Wang, Bryce Parkinson, et al.Journal of the National Cancer Institute|February 18, 2015
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancerAna M Gonzalez-Angulo, Ian Krop, Argun Akcakanat, et al.Cancer|January 11, 2005
Breast conservation after neoadjuvant chemotherapyAllen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.Nature|October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowthLin Zhang, Siyuan Zhang, Jun Yao, et al.Breast Cancer Research and Treatment|June 16, 2021
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scoresTakeo Fujii, Hiroko Masuda, Yee Chung Cheng, et al.Oncotarget|November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patientsReva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.Pageof 50